Advanced Therapy Medicinal Products (ATMP) CDMO Market
According to Intent Market Research, the Advanced Therapy Medicinal Products CDMO Market is expected to grow from USD 5.2 billion in 2023 at a CAGR of 21.6% to touch USD 20.4 billion by 2030. The Advanced Therapy Medicinal Products CDMO Market is dominated by key players such as Lonza Group, Samsung Biologics, WuXi AppTec, Boehringer Ingelheim, Catalent, Kite Pharma (Gilead Sciences), Novartis (Kymriah), Sartorius Stedim Biotech, Regeneron Pharmaceuticals, VWR International, Cell and Gene Therapy Catapult, WuXi Advanced Therapies, AbbVie, Baxter International, Merck Group.